Approval · Notice of Compliance 390 · 2002
PROCYTOX: Notice of Compliance 390
Issued February 4, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 390
- Date
- February 4, 2002
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
Medicinal ingredients
- CYCLOPHOSPHAMIDE 50 MG per TAB
- CYCLOPHOSPHAMIDE 25 MG per TAB
- CYCLOPHOSPHAMIDE 2,000 MG per VIAL
- CYCLOPHOSPHAMIDE 1,000 MG per VIAL
- CYCLOPHOSPHAMIDE 200 MG per VIAL
- CYCLOPHOSPHAMIDE 500 MG per VIAL